These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32810476)

  • 21. New 2,4-diamino-5-(2',5'-substituted benzyl)pyrimidines as potential drugs against opportunistic infections of AIDS and other immune disorders. Synthesis and species-dependent antifolate activity.
    Rosowsky A; Forsch RA; Sibley CH; Inderlied CB; Queener SF
    J Med Chem; 2004 Mar; 47(6):1475-86. PubMed ID: 14998335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlations of inhibitor kinetics for Pneumocystis jirovecii and human dihydrofolate reductase with structural data for human active site mutant enzyme complexes.
    Cody V; Pace J; Makin J; Piraino J; Queener SF; Rosowsky A
    Biochemistry; 2009 Mar; 48(8):1702-11. PubMed ID: 19196009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a lipophilic antifolate resistance provoked by treatment of mammalian cells with the antiparasitic agent pyrimethamine.
    Assaraf YG; Slotky JI
    J Biol Chem; 1993 Feb; 268(6):4556-66. PubMed ID: 8440739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequence-specific 1H, 13C and 15N assignment of the TMP-resistant dihydrofolate reductase mutant DHFR(F98Y) in the ternary complex with TMP and NADPH.
    Altmann S; Labhardt AM; Senn H; Wüthrich K
    J Biomol NMR; 1997 Jun; 9(4):445-6. PubMed ID: 9255948
    [No Abstract]   [Full Text] [Related]  

  • 25. Kinetic and structural analysis for potent antifolate inhibition of Pneumocystis jirovecii, Pneumocystis carinii, and human dihydrofolate reductases and their active-site variants.
    Cody V; Pace J; Queener SF; Adair OO; Gangjee A
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2669-77. PubMed ID: 23545530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A plasmid-encoded dihydrofolate reductase from trimethoprim-resistant bacteria has a novel D2-symmetric active site.
    Narayana N; Matthews DA; Howell EE; Nguyen-huu X
    Nat Struct Biol; 1995 Nov; 2(11):1018-25. PubMed ID: 7583655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crystal structure of dihydrofolate reductase from Plasmodium vivax: pyrimethamine displacement linked with mutation-induced resistance.
    Kongsaeree P; Khongsuk P; Leartsakulpanich U; Chitnumsub P; Tarnchompoo B; Walkinshaw MD; Yuthavong Y
    Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13046-51. PubMed ID: 16135570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro efficacy of new antifolates against trimethoprim-resistant Bacillus anthracis.
    Barrow EW; Dreier J; Reinelt S; Bourne PC; Barrow WW
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4447-52. PubMed ID: 17875993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potency boost of a
    Aragaw WW; Lee BM; Yang X; Zimmerman MD; Gengenbacher M; Dartois V; Chui WK; Jackson CJ; Dick T
    Proc Natl Acad Sci U S A; 2021 Jun; 118(25):. PubMed ID: 34161270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacoinformatic Study on the Selective Inhibition of the Protozoan Dihydrofolate Reductase Enzymes.
    Sharma VK; Abbat S; Bharatam PV
    Mol Inform; 2017 Nov; 36(11):. PubMed ID: 28605138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural Insights into Mycobacterium tuberculosis Rv2671 Protein as a Dihydrofolate Reductase Functional Analogue Contributing to para-Aminosalicylic Acid Resistance.
    Cheng YS; Sacchettini JC
    Biochemistry; 2016 Feb; 55(7):1107-19. PubMed ID: 26848874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1H/15N HSQC NMR studies of ligand carboxylate group interactions with arginine residues in complexes of brodimoprim analogues and Lactobacillus casei dihydrofolate reductase.
    Morgan WD; Birdsall B; Nieto PM; Gargaro AR; Feeney J
    Biochemistry; 1999 Feb; 38(7):2127-34. PubMed ID: 10026296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium dihydrofolate reductases by 2,4-diamino-5-[2-methoxy-5-(omega-carboxyalkyloxy)benzyl]pyrimidines: marked improvement in potency relative to trimethoprim and species selectivity relative to piritrexim.
    Rosowsky A; Forsch RA; Queener SF
    J Med Chem; 2002 Jan; 45(1):233-41. PubMed ID: 11754594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene sequence.
    Eldin de Pécoulas P; Basco LK; Tahar R; Ouatas T; Mazabraud A
    Gene; 1998 Apr; 211(1):177-85. PubMed ID: 9573357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential antifolate resistance determinants and genotypic variation in the bifunctional dihydrofolate reductase-thymidylate synthase gene from human and bovine isolates of Cryptosporidium parvum.
    Vásquez JR; Goozé L; Kim K; Gut J; Petersen C; Nelson RG
    Mol Biochem Parasitol; 1996 Aug; 79(2):153-65. PubMed ID: 8855552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular modeling toward selective inhibitors of dihydrofolate reductase from the biological warfare agent Bacillus anthracis.
    Giacoppo JO; Mancini DT; Guimarães AP; Gonçalves AS; da Cunha EF; França TC; Ramalho TC
    Eur J Med Chem; 2015 Feb; 91():63-71. PubMed ID: 24985033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The structure and competitive substrate inhibition of dihydrofolate reductase from Enterococcus faecalis reveal restrictions to cofactor docking.
    Bourne CR; Wakeham N; Webb N; Nammalwar B; Bunce RA; Berlin KD; Barrow WW
    Biochemistry; 2014 Feb; 53(7):1228-38. PubMed ID: 24495113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterologous expression and characterization of the bifunctional dihydrofolate reductase-thymidylate synthase enzyme of Toxoplasma gondii.
    Trujillo M; Donald RG; Roos DS; Greene PJ; Santi DV
    Biochemistry; 1996 May; 35(20):6366-74. PubMed ID: 8639582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigating the anti-cancer potential of pyrimethamine analogues through a modern chemical biology lens.
    Brown JI; Persaud R; Iliev P; Karmacharya U; Attarha S; Sahile H; Olsen JE; Hanke D; Idowu T; Frank DA; Frankel A; Williams KC; Page BDG
    Eur J Med Chem; 2024 Jan; 264():115971. PubMed ID: 38071795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional cloning of Bacillus anthracis dihydrofolate reductase and confirmation of natural resistance to trimethoprim.
    Barrow EW; Bourne PC; Barrow WW
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4643-9. PubMed ID: 15561838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.